22-43046471-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012263.5(TTLL1):āc.1081A>Gā(p.Ile361Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 152,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_012263.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL1 | NM_012263.5 | c.1081A>G | p.Ile361Val | missense_variant | 10/11 | ENST00000266254.12 | NP_036395.1 | |
TTLL1-AS1 | NR_125362.1 | n.1771+5170T>C | intron_variant, non_coding_transcript_variant | |||||
TTLL1 | NR_027779.2 | n.1389A>G | non_coding_transcript_exon_variant | 11/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL1 | ENST00000266254.12 | c.1081A>G | p.Ile361Val | missense_variant | 10/11 | 1 | NM_012263.5 | ENSP00000266254 | P1 | |
TTLL1-AS1 | ENST00000443063.1 | n.1771+5170T>C | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152060Hom.: 0 Cov.: 31
GnomAD4 exome Cov.: 30
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152060Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74266
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.1081A>G (p.I361V) alteration is located in exon 10 (coding exon 8) of the TTLL1 gene. This alteration results from a A to G substitution at nucleotide position 1081, causing the isoleucine (I) at amino acid position 361 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at